ChemoMetec logo — We are a worldwide leading manufacturer in cell counting and...

ChemoMetec

We are a worldwide leading manufacturer in cell counting and analysis. Born in Scandinavia, operating globally.

Founded 1997 Denmark Denmark 191 employees IPO Total: $1.72M Biotechnology, Robotics

General Information

Company Name ChemoMetec
Founded Year 1997
Location Denmark Denmark
Employees 191
Industries Biotechnology, Robotics
Funding Stage IPO
Business Model B2B, D2C, E Commerce
Revenue Model Product Sales, Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with ChemoMetec. To contact ChemoMetec, visit chemometec.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ChemoMetec compare?

A PDF of ChemoMetec and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ChemoMetec soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ChemoMetec

ChemoMetec, with the slogan "We are a worldwide leading manufacturer in cell counting and analysis.", is a prominent player in the biotechnology and robotics industries. Founded in 1997 and headquartered in Denmark, the company has carved a niche in developing high-precision cell counting and analysis equipment.

Specializing in delivering consistent and high-quality data, ChemoMetec serves thousands of customers across the biotech, pharma, and academic sectors globally. The company's products are designed, manufactured, and tested in Denmark, ensuring expert craftsmanship and use of quality materials.

Experiencing exponential growth, ChemoMetec is aiming to become the number one provider in life sciences. Despite its expansive reach, details of the company's capital strategy remain limited with the last recorded investment being a €180.00K grant from the Eurostars SME programme in September 2013.

Business keywords: Cell Counting, Cell Analysis, Biotech Equipment, Pharmaceutical Applications, Flow Cytometers, Automated Cell Counters, GMP Quality Control, Clinical Diagnostics, Cell Therapy, Microfluidic Technology, NucleoCounting Technology, Research and Development, Bioprocessing, Image Cytometry, Automation Machinery Manufacturing

Services & Products

Automated Cell Counting and Analysis
Bioinstrumentation Development
Service Plans for Instruments
Operator Training & Certification

Target Customers

Biotech Companies Pharmaceutical Companies Academic Researchers Cell and Gene Therapy Labs

Pricing

as listed on Sep 30, 2026

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €180.00K 1
Eurostars SME programme
01 Sep 2013
IPO $1.54M -
01 Dec 2006

ChemoMetec Alternatives & Competitors

View All Alternatives
ChemoMetec vs
Culture Biosciences
Culture Biosciences United States

Grow Smarter with Culture

Series C
67 employees
Automation, Biotechnology
ChemoMetec vs

We make open-source liquid handling robots for scientists.

Series C
196 employees
AI, Biotechnology
ChemoMetec vs
Hamilton Company
Hamilton Company United States

Specializing in precision measurement devices, automated liquid handling workstations, and sample ma...

1129 employees
Biotechnology, Life Sciences

FAQ About ChemoMetec

We are a worldwide leading manufacturer in cell counting and analysis. Born in Scandinavia, operating globally.
ChemoMetec was founded in 1997.
ChemoMetec is headquartered in Denmark.
ChemoMetec operates in Biotechnology and Robotics. Its work centres on Cell Counting, Cell Analysis, Biotech Equipment and Pharmaceutical Applications. Its customers include Biotech Companies, Pharmaceutical Companies and Academic Researchers.
ChemoMetec has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales, Service Fee and Subscription.
As listed on ChemoMetec's pricing page on Sep 30, 2026: On request.
ChemoMetec has approximately 191 employees.
ChemoMetec has completed 2 funding rounds, raising a total of $1.72M. The latest funding stage is IPO.
ChemoMetec offers: Automated Cell Counting and Analysis, Bioinstrumentation Development, Service Plans for Instruments, Operator Training & Certification.
Top alternatives and competitors to ChemoMetec include Culture Biosciences, Opentrons Labworks Inc., Hamilton Company, Arctoris, mo:re. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ChemoMetec and Culture Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ChemoMetec, https://bouncewatch.com/company/chemometec, updated 29 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes